Vés al contingut

A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients

Obert
  • Codi protocol: VKTX01_CSL300_3001
  • Codi EudraCT: 2018-003682-34
  • Grup de recerca: Nefrologia i Trasplantament Renal
  • Servei: Nefrologia
  • Investigador/a principal:  Serón Micas, Daniel
  • Fase: Fase III
  • Estat reclutament: Reclutant voluntaris